keyword
https://read.qxmd.com/read/38607077/ex-pluribus-unum-the-cd4-t-cell-response-against-influenza-a-virus
#21
REVIEW
Caroline M Finn, K Kai McKinstry
Current Influenza A virus (IAV) vaccines, which primarily aim to generate neutralizing antibodies against the major surface proteins of specific IAV strains predicted to circulate during the annual 'flu' season, are suboptimal and are characterized by relatively low annual vaccine efficacy. One approach to improve protection is for vaccines to also target the priming of virus-specific T cells that can protect against IAV even in the absence of preexisting neutralizing antibodies. CD4 T cells represent a particularly attractive target as they help to promote responses by other innate and adaptive lymphocyte populations and can also directly mediate potent effector functions...
April 5, 2024: Cells
https://read.qxmd.com/read/38605941/is-the-exquisite-specificity-of-lymphocytes-generated-by-thymic-selection-or-due-to-evolution
#22
JOURNAL ARTICLE
Rob J De Boer, Can Kesmir, Alan S Perelson, José A M Borghans
We have previously argued that the antigen receptors of T and B lymphocytes evolved to be sufficiently specific to avoid massive deletion of clonotypes by negative selection. Their optimal 'specificity' level, i.e., probability of binding any particular epitope, was shown to be inversely related to the number of self-antigens that the cells have to be tolerant to. Experiments have demonstrated that T lymphocytes also become more specific during negative selection in the thymus, because cells expressing the most crossreactive receptors have the highest likelihood of binding a self-antigen, and hence to be tolerized (i...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38603859/the-association-between-expression-of-cd200-on-b-lymphocytes-and-the-count-of-eosinophils-and-basophils-in-atopic-dermatitis-patients-with-and-without-dupilumab-therapy-pilot-study
#23
JOURNAL ARTICLE
J Čelakovská, E Čermákova, P Boudková, C Andrýs, J Krejsek
BACKGROUND: Eosinophils and basophils are implicated in allergic reactions, and the molecule CD200 on B cells may have regulatory functions. Assessing the associations between the expression of CD200 on B lymphocytes and eosinophils and basophils helps unravel the complex immune interactions in atopic dermatitis, aiding in targeted therapeutic approaches. OBJECTIVE: The aim of our study is to evaluate the association between the count of eosinophils, basophils, CD16+ eosinophils, CD203+ basophils, the expression of activation marker CD200 on B cells and on their subsets in patients suffering from atopic dermatitis with and without dupilumab and in control group...
April 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38601437/hyperprogressive-disease-under-anti-pd-1-rechallenge-after-initial-response-to-anti-pd-1-treatment-for-non-small-cell-lung-cancer-a-case-report
#24
Shiting Xu, Takehito Shukuya, Shoko Shimamura, Takuo Hayashi, Yoshihiko Sato, Hitomi Shiozaki, Toshihiko Nishioki, Koichi Nishino, Motoyasu Kato, Aritoshi Hattori, Naoko Shimada, Kenji Suzuki, Shigehisa Kitano, Kazuhisa Takahashi
BACKGROUND: Hyperprogressive disease is an unexpected response pattern observed in immune checkpoint therapy and associated with poor prognosis. The rechallenge of programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) inhibitors can be a treatment option in non-small cell lung cancer (NSCLC) patients who once responded to them. Here, we reported the hyperprogressive phenomenon after PD-1/PD-L1 rechallenge in a patient with NSCLC. CASE DESCRIPTION: This case report described a patient with recurrent large cell lung cancer undergoing hyperprogressive disease with pleural and pericardial dissemination shortly after the pembrolizumab rechallenge, although he had a favorable response to the initial pembrolizumab treatment...
March 29, 2024: Translational Lung Cancer Research
https://read.qxmd.com/read/38601156/targeting-cd73-with-flavonoids-inhibits-cancer-stem-cells-and-increases-lymphocyte-infiltration-in-a-triple-negative-breast-cancer-mouse-model
#25
JOURNAL ARTICLE
Karan Mediratta, Sara El-Sahli, Marie Marotel, Muhammad Z Awan, Melanie Kirkby, Ammar Salkini, Reem Kurdieh, Salman Abdisalam, Amit Shrestha, Chiara Di Censo, Andrew Sulaiman, Sarah McGarry, Jessie R Lavoie, Zhen Liu, Seung-Hwan Lee, Xuguang Li, Giuseppe Sciumè, Vanessa M D'Costa, Michele Ardolino, Lisheng Wang
INTRODUCTION: Chemotherapy remains the mainstay treatment for triple-negative breast cancer (TNBC) due to the lack of specific targets. Given a modest response of immune checkpoint inhibitors in TNBC patients, improving immunotherapy is an urgent and crucial task in this field. CD73 has emerged as a novel immunotherapeutic target, given its elevated expression on tumor, stromal, and specific immune cells, and its established role in inhibiting anti-cancer immunity. CD73-generated adenosine suppresses immunity by attenuating tumor-infiltrating T- and NK-cell activation, while amplifying regulatory T cell activation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38600952/higher-t-central-and-lower-effector-memory-cells-in-bipolar-disorder-a-differentiation-abnormality
#26
JOURNAL ARTICLE
Magdalini Ioannou, Maria S Simon, Jenny Borkent, Annemarie Wijkhuijs, Raf Berghmans, Bartholomeus C M Haarman, Hemmo A Drexhage
The aim of this study was to elucidate the nature of T cell abnormalities in bipolar disorder (BD). With the use of multicolor flow cytometry, we first quantified the composition of the different memory and pro-inflammatory immune subpopulations in samples of 58 patients with BD and compared them to 113 healthy controls. Second, to assess if cytomegalovirus infection was related to the resulted immune subpopulation compositions in the two groups, we measured cytomegalovirus-specific antibodies in serum. Thirdly, we assessed differences between the two groups in the serum levels of the immune cell differentiation factor interleukin-7...
July 2024: Brain, behavior, & immunity health
https://read.qxmd.com/read/38600583/a-paclitaxel-hyaluronan-conjugate-oncofid-p-b%C3%A2-in-patients-with-bcg-unresponsive-carcinoma-in-situ-of-the-bladder-a-dynamic-assessment-of-the-tumor-microenvironment
#27
JOURNAL ARTICLE
Anna Tosi, Beatrice Parisatto, Enrico Gaffo, Stefania Bortoluzzi, Antonio Rosato
BACKGROUND: The intravesical instillation of the paclitaxel-hyaluronan conjugate ONCOFID-P-B™ in patients with bacillus Calmette-Guérin (BCG)-unresponsive bladder carcinoma in situ (CIS; NCT04798703 phase I study), induced 75 and 40% of complete response (CR) after 12 weeks of intensive phase and 12 months of maintenance phase, respectively. The aim of this study was to provide a detailed description of the tumor microenvironment (TME) of ONCOFID-P-B™-treated BCG-unresponsive bladder CIS patients enrolled in the NCT04798703 phase I study, in order to identify predictive biomarkers of response...
April 10, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38593338/vitamin-a-treated-natural-killer-cells-reduce-interferon-gamma-production-and-support-regulatory-t-cell-differentiation
#28
JOURNAL ARTICLE
Mingeum Jeong, Francesco Cortopassi, Jia-Xiang See, Carolina De La Torre, Adelheid Cerwenka, Ana Stojanovic
Natural killer (NK) cells are innate cytotoxic lymphocytes that contribute to immune responses against stressed, transformed, or infected cells. NK cell effector functions are regulated by microenvironmental factors, including cytokines, metabolites, and nutrients. Vitamin A is an essential micronutrient that plays an indispensable role in embryogenesis and development, but was also reported to regulate immune responses. However, the role of vitamin A in regulating NK cell functions remains poorly understood...
April 9, 2024: European Journal of Immunology
https://read.qxmd.com/read/38591522/convergence-plasticity-and-tissue-residence-of-regulatory-t-cell-response-via-tcr-repertoire-prism
#29
JOURNAL ARTICLE
Tatyana O Nakonechnaya, Bruno Moltedo, Ekaterina V Putintseva, Sofya Leyn, Dmitry A Bolotin, Olga V Britanova, Mikhail Shugay, Dmitriy M Chudakov
Suppressive function of regulatory T cells (Treg) is dependent on signaling of their antigen receptors triggered by cognate self, dietary, or microbial peptides presented on MHC II. However, it remains largely unknown whether distinct or shared repertoires of Treg TCRs are mobilized in response to different challenges in the same tissue or the same challenge in different tissues. Here we use a fixed TCRβ chain FoxP3-GFP mouse model to analyze conventional (eCD4) and regulatory (eTreg) effector TCRα repertoires in response to six distinct antigenic challenges to the lung and skin...
April 9, 2024: ELife
https://read.qxmd.com/read/38590878/incorporating-machine-learning-and-ppi-networks-to-identify-mitochondrial-fission-related-immune-markers-in-abdominal-aortic-aneurysms
#30
JOURNAL ARTICLE
Yi-Jiang Liu, Rui Li, Di Xiao, Cui Yang, Yan-Lin Li, Jia-Lin Chen, Zhan Wang, Xin-Guo Zhao, Zhong-Gui Shan
PURPOSE: The aim of this study is to investigate abdominal aortic aneurysm (AAA), a disease characterised by inflammation and progressive vasodilatation, for novel gene-targeted therapeutic loci. METHODS: To do this, we used weighted co-expression network analysis (WGCNA) and differential gene analysis on samples from the GEO database. Additionally, we carried out enrichment analysis and determined that the blue module was of interest. Additionally, we performed an investigation of immune infiltration and discovered genes linked to immune evasion and mitochondrial fission...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38589566/development-and-experimental-validation-of-an-energy-metabolism-related-gene-signature-for-diagnosing-of-osteoporosis
#31
JOURNAL ARTICLE
Yao Lu, Wen Wen, Qiang Huang, Ning Duan, Ming Li, Kun Zhang, Zhong Li, Liang Sun, Qian Wang
Osteoporosis is usually caused by excessive bone resorption and energy metabolism plays a critical role in the development of osteoporosis. However, little is known about the role of energy metabolism-related genes in osteoporosis. This study aimed to explore the important energy metabolism-related genes involved in the development of osteoporosis and develop a diagnosis signature for osteoporosis. The GSE56814, GSE62402, and GSE7158 datasets were downloaded from the NCBI Gene Expression Omnibus. The intersection of differentially expressed genes between high and low levels of body mineral density (BMD) and genes related to energy metabolism were screened as differentially expressed energy metabolism genes (DE-EMGs)...
April 8, 2024: Scientific Reports
https://read.qxmd.com/read/38589406/stroma-infiltrating-t-cell-spatiotypes-define-immunotherapy-outcomes-in-adolescent-and-young-adult-patients-with-melanoma
#32
JOURNAL ARTICLE
Xinyu Bai, Grace H Attrill, Tuba N Gide, Peter M Ferguson, Kazi J Nahar, Ping Shang, Ismael A Vergara, Umaimainthan Palendira, Ines Pires da Silva, Matteo S Carlino, Alexander M Menzies, Georgina V Long, Richard A Scolyer, James S Wilmott, Camelia Quek
The biological underpinnings of therapeutic resistance to immune checkpoint inhibitors (ICI) in adolescent and young adult (AYA) melanoma patients are incompletely understood. Here, we characterize the immunogenomic profile and spatial architecture of the tumor microenvironment (TME) in AYA (aged ≤ 30 years) and older adult (aged 31-84 years) patients with melanoma, to determine the AYA-specific features associated with ICI treatment outcomes. We identify two ICI-resistant spatiotypes in AYA patients with melanoma showing stroma-infiltrating lymphocytes (SILs) that are distinct from the adult TME...
April 8, 2024: Nature Communications
https://read.qxmd.com/read/38588949/gut-microbiota-as-a-key-regulator-of-intestinal-mucosal-immunity
#33
REVIEW
Jing Wang, Mei He, Ming Yang, Xiaopeng Ai
Gut microbiota is a complex microbial community with the ability of maintaining intestinal health. Intestinal homeostasis largely depends on the mucosal immune system to defense external pathogens and promote tissue repair. In recent years, growing evidence revealed the importance of gut microbiota in shaping intestinal mucosal immunity. Therefore, according to the existing findings, this review first provided an overview of intestinal mucosal immune system before summarizing the regulatory roles of gut microbiota in intestinal innate and adaptive immunity...
May 15, 2024: Life Sciences
https://read.qxmd.com/read/38583170/accelerating-the-development-of-genetically-engineered-cellular-therapies-a-framework-for-extrapolating-data-across-related-products
#34
JOURNAL ARTICLE
Mark D Stewart, Michael Kalos, Vicki Coutinho, Marc Better, Jonathan Jazayeri, Jennifer Yohrling, Julie Jadlowsky, Miriam Fuchs, Shalini Gidwani, Carsten Goessl, Patrick J Hanley, Jane Healy, Wen Liu, Brittany A McKelvey, Laura Pearce, Shari Pilon-Thomas, Hillary S Andrews, Monica Veldman, Judy Vong, Susan P Weinbach, Jeff D Allen
BACKGROUND: Significant advancements have been made in the field of cellular therapy as anti-cancer treatments, with the approval of chimeric antigen receptor (CAR)-T cell therapies and the development of other genetically engineered cellular therapies. CAR-T cell therapies have demonstrated remarkable clinical outcomes in various hematological malignancies, establishing their potential to change the current cancer treatment paradigm. Due to the increasing importance of genetically engineered cellular therapies in the oncology treatment landscape, implementing strategies to expedite development and evidence generation for the next generation of cellular therapy products can have a positive impact on patients...
March 16, 2024: Cytotherapy
https://read.qxmd.com/read/38583001/natural-killer-cell-subsets-in-tumor-draining-lymph-nodes-of-patients-with-bladder-cancer-and-their-clinical-implications
#35
JOURNAL ARTICLE
Ali Ariafar, Erfan Kohansal, Amirhassan Mousania, Zahra Faghih
BACKGROUND: Natural killer (NK) cells are crucial innate components in anti-tumor immunity. However, the clinical impacts and their phenotypes in bladder cancer (BC) remain unclear. OBJECTIVE: To assess the clinical significance of NK cell subsets in tumor-draining lymph nodes of patients with BC. METHODS: In a cross-sectional study, pelvic lymph nodes were obtained from 49 untreated patients with BC. Mononuclear cells were isolated and immunophenotyped using CD3, CD56, CD16, CD27, and CD11b markers...
April 7, 2024: Iranian Journal of Immunology: IJI
https://read.qxmd.com/read/38580347/induction-of-regulatory-t-cells-and-efficacy-of-low-dose-interleukin-2-in-systemic-sclerosis-interventional-open-label-phase-1-phase-2a-study
#36
JOURNAL ARTICLE
François Barde, Roberta Lorenzon, Eric Vicaut, Sébastien Rivière, Patrice Cacoub, Carlotta Cacciatore, Michelle Rosenzwajg, Anne Daguenel-Nguyen, Olivier Fain, David Klatzmann, Arsène Mekinian
BACKGROUND: Systemic sclerosis (SSc) is a chronic autoimmune disease, with impaired immune response, increased fibrosis and endothelial dysfunction. Regulatory T cells (Tregs), which are essential to control inflammation, tissue repair and autoimmunity, have a decreased frequency and impaired function in SSc patients. Low-dose interleukin-2 (IL-2LD ) can expand and activate Tregs and has, therefore, a therapeutic potential in SSc. OBJECTIVE: We aimed to assess the safety and biological efficacy of IL-2LD in patients with SSc...
April 4, 2024: RMD Open
https://read.qxmd.com/read/38578569/rapamycin-controls-lymphoproliferation-and-reverses-t-cell-responses-in-a-patient-with-a-novel-stim1-loss-of-function-deletion
#37
JOURNAL ARTICLE
Ibrahim Serhat Karakus, Mehmet Cihangir Catak, Alexandra Frohne, Feyza Bayram Catak, Melek Yorgun Altunbas, Royala Babayeva, Sevgi Kostel Bal, Sevgi Bilgic Eltan, Ezgi Yalcin Gungoren, Fehim Esen, Itir Ebru Zemheri, Elif Karakoc-Aydiner, Ahmet Ozen, Suar Caki-Kilic, Michael J Kraakman, Kaan Boztug, Safa Baris
PURPOSE: Deficiency of stromal interaction molecule 1 (STIM1) results in combined immunodeficiency accompanied by extra-immunological findings like enamel defects and myopathy. We here studied a patient with a STIM1 loss-of-function mutation who presented with severe lymphoproliferation. We sought to explore the efficacy of the mTOR inhibitor rapamycin in controlling disease manifestations and reversing aberrant T-cell subsets and functions, which has never been used previously in this disorder...
April 5, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38577535/hepatocellular-carcinoma-immune-microenvironment-and-check-point-inhibitors-current-status
#38
REVIEW
Tarana Gupta, Nikhil Sai Jarpula
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and has a high mortality rate. The Barcelona Clinic Liver Cancer staging system in addition to tumor staging also links the modality of treatment available to a particular stage. The recent description of the tumor microenvironment (TME) in HCC has provided a new concept of immunogenicity within the HCC. Virus-related HCC has been shown to be more immunogenic with higher expression of cytotoxic T lymphocytes and decreased elements for immunosuppression such as regulatory T cells...
March 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38575045/duodenal-mucosa-of-untreated-celiac-disease-patients-has-altered-expression-of-the-gas6-and-pros1-and-the-negative-regulator-tyrosine-kinase-tam-receptors-subfamily
#39
JOURNAL ARTICLE
Federico Perez, María Luz Iribarren, Cinthia Mariel Olexen, Carolina Naymé Ruera, Andrea Emilse Errasti, Luciana Guzman, Laura Garbi, Eugenio Antonio Carrera-Silva, Fernando Gabriel Chirdo
Celiac disease (CD) is an immune-driven disease characterized by tissue damage in the small intestine of genetically-susceptible individuals. We evaluated here a crucial immune regulatory pathway involving TYRO3, AXL, and MERTK (TAM) receptors and their ligands PROS1 and GAS6 in duodenal biopsies of controls and CD patients. We found increased GAS6 expression associated with downregulation of PROS1 and variable TAM receptors levels in duodenum tissue of CD patients. Interestingly, CD3+ lymphocytes, CD68+ , CD11c+ myeloid and epithelial cells, showed differential expressions of TAM components comparing CD vs controls...
April 2, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38570836/gut-microbiota-derived-butyrate-restores-impaired-regulatory-t-cells-in-patients-with-achr-myasthenia-gravis-via-mtor-mediated-autophagy
#40
JOURNAL ARTICLE
Long He, Zhuotai Zhong, Shuting Wen, Peiwu Li, Qilong Jiang, Fengbin Liu
More than 80% of patients with myasthenia gravis (MG) are positive for anti-acetylcholine receptor (AChR) antibodies. Regulatory T cells (Tregs) suppress overproduction of these antibodies, and patients with AChR antibody-positive MG (AChR MG) exhibit impaired Treg function and reduced Treg numbers. The gut microbiota and their metabolites play a crucial role in maintaining Treg differentiation and function. However, whether impaired Tregs correlate with gut microbiota activity in patients with AChR MG remains unknown...
April 3, 2024: Cell Communication and Signaling: CCS
keyword
keyword
17044
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.